OcuTerra Therapeutics’ Post

Be sure to download our 2024 Glaucoma Report by Eyes On Eyecare! This report reflects the opinions of nearly 400 optometrists across diverse professional backgrounds and practice settings. Utilizing a mixed-methods approach—combining quantitative and qualitative data through structured and open-ended questions—the 2024 Glaucoma Report explores prevalence, preparedness, preferences in disease diagnostics and management, confidence in treatment, feelings surrounding co-management, and more. Click below to read —and download the report—to garner insight into the challenges eyecare professionals are facing with glaucoma and the innovative ways they are choosing to overcome them. bit.ly/45LXHHs

Drug-Eluting Balloon technology in coronary de novo disease? PD Dr. Kambis Mashayekhi, with the support of Dr. Stefan Harb in Graz hospital share opinions on how #DEB associated with DES can help treat long diffuse disease while discussing the largest DEB study ever initiated: the SELUTION DeNovo Study has the potential to further transform #PCI. #CoronaryArteryDisease #InterventionalCardiology #DCB #SELUTIONSLR #SELUTIONDeNovo

🔬 Accepted Poster Presentation: Biomed Diagnostics at ASM Microbe 2024 Join us at ASM Microbe 2024, where Biomed Diagnostics, in collaboration with the Centers for Disease Control and Prevention (CDC), will present our latest research. Our study, "Extending Viability Time and Temperature Parameters for InPouch™ TV Trichomonas vaginalis Transportation," offers evidence supporting expanded time and temperature conditions for transporting T. vaginalis. This research suggests modifications to current transportation protocols by demonstrating that T. vaginalis specimens can remain viable under broader time and temperature ranges. These findings aim to provide healthcare providers and laboratories with data to consider more flexible logistical options, potentially enhancing diagnostic accuracy. 📍Read the press release here: https://hubs.ly/Q02wQcts0 #ASMMicrobe2024 #BiomedDiagnostics #CDC #PublicHealth #ScientificResearch #Diagnostics #CultureDiagnostics #InfectiousDisease #SpecimenTransport

🌟 Quantitative CT methods like FRI are on the verge of becoming an essential part of the toolkit for interstitial lung disease research, but some barriers to mainstream adoption remain. In a recent article published in the European Respiratory Review, Dr. Simon LF Walsh and other members of the Open Source Imaging Consortium (OSIC) (including our CEO, Jan De Backer) provide a comprehensive review of the state-of-the-art of qCT in ILD research and identify key steps in unleashing its full potential to improve the lives of people living with these diseases. #qct #FRI #lunghealth 👇 Read the article here:

Dr. Shazia Mohsin, Associate Professor and Head of Non Invasive Imaging Lab at SIUT unravels the intricacies of diagnosing Congenital Heart Diseases. ❤️🫁 👩⚕️ In this engaging video, Dr. Shazia shares her expertise in non-invasive imaging techniques that play a crucial role in accurately diagnosing these conditions. Let's empower ourselves with knowledge and promote early detection for healthier hearts! 💪 #CHDDiagnosis #CongenitalHeartDisease #NonInvasiveImaging #SIUT #HeartHealth #EarlyDetection #HeartDiagnosis

🔬 Accepted Poster Presentation: Biomed Diagnostics at ASM Microbe 2024 Join us at ASM Microbe 2024, where Biomed Diagnostics, in collaboration with the Centers for Disease Control and Prevention (CDC), will present our latest research. Our study, "Extending Viability Time and Temperature Parameters for InPouch™ TV Trichomonas vaginalis Transportation," offers evidence supporting expanded time and temperature conditions for transporting T. vaginalis. This research suggests modifications to current transportation protocols by demonstrating that T. vaginalis specimens can remain viable under broader time and temperature ranges. These findings aim to provide healthcare providers and laboratories with data to consider more flexible logistical options, potentially enhancing diagnostic accuracy. 📍Read the press release here: https://hubs.ly/Q02wKMwJ0 #ASMMicrobe2024 #BiomedDiagnostics #CDC #PublicHealth #ScientificResearch #Diagnostics #CultureDiagnostics #InfectiousDisease #SpecimenTransport

🔬 Accepted Poster Presentation: Biomed Diagnostics at ASM Microbe 2024 Join us at ASM Microbe 2024, where Biomed Diagnostics, in collaboration with the Centers for Disease Control and Prevention (CDC), will present our latest research. Our study, "Extending Viability Time and Temperature Parameters for InPouch™ TV Trichomonas vaginalis Transportation," offers evidence supporting expanded time and temperature conditions for transporting T. vaginalis. This research suggests modifications to current transportation protocols by demonstrating that T. vaginalis specimens can remain viable under broader time and temperature ranges. These findings aim to provide healthcare providers and laboratories with data to consider more flexible logistical options, potentially enhancing diagnostic accuracy. 📍Read the press release here: https://hubs.ly/Q02wQbG30 #ASMMicrobe2024 #BiomedDiagnostics #CDC #PublicHealth #ScientificResearch #Diagnostics #CultureDiagnostics #InfectiousDisease #SpecimenTransport

🔬 Accepted Poster Presentation: Biomed Diagnostics at ASM Microbe 2024 Join us at ASM Microbe 2024, where Biomed Diagnostics, in collaboration with the Centers for Disease Control and Prevention (CDC), will present our latest research. Our study, "Extending Viability Time and Temperature Parameters for InPouch™ TV Trichomonas vaginalis Transportation," offers evidence supporting expanded time and temperature conditions for transporting T. vaginalis. This research suggests modifications to current transportation protocols by demonstrating that T. vaginalis specimens can remain viable under broader time and temperature ranges. These findings aim to provide healthcare providers and laboratories with data to consider more flexible logistical options, potentially enhancing diagnostic accuracy. 📍Request a meeting with our team here: https://hubs.ly/Q02yVYBN0 #ASMMicrobe2024 #ASM #BiomedDiagnostics #CDC #PublicHealth #ScientificResearch #Diagnostics #CultureDiagnostics #InfectiousDisease #SpecimenTransport

How has our definition of non-CF bronchiectasis evolved in recent years? How does this updated definition impact the way we address bronchiectasis in clinical practice? In this brief program, Dr. Colin Swenson breaks down important changes in our clinical understanding of bronchiectasis. He explains why bronchiectasis is no longer viewed as a rare disease, how certain patient populations are affected more frequently than previously believed, and other key changes in our knowledge of the etiology and mortality of this condition. Discover insights on the evolving definition of bronchiectasis and how our changing understanding affects our approach to management. Stay up to date on the latest in bronchiectasis: https://bit.ly/3MXhR9l

With greater understanding, comes greater patient outcomes. While you focus on autoimmunity diagnosis, we’ll be at your side, all the way.     Visit us at the International Congress on Autoimmunity 2024 in Ljubljana, Slovenia, 17-20 May, where you’ll trace the steps of a systemic autoimmune rheumatic disease patient journey. You’ll also uncover effective strategies for selecting the most pertinent, relevant tests, utilizing autoimmune serology results to advance toward precision medicine.     Join us at Booth #13 and discover better patient management, together.   #rheumaticdisease #autoimmunity #symposium #autoimmunity2024 #InternationalCongressOnAutoimmunity #Ljubljana2024 #polyautoimmunity #antiphospholipidsyndrome